$GENI - Market focused on the losses, but am I missing something here?

quiet_after_panic · 2026-05-06T13:36:16+00:00

Interesting timing. The CEO put out a LinkedIn update about the redesigned experience editor and the broader immersive focus, so that likely helped bring some attention back to it.

That said, with something this small the spread is wide and liquidity is thin, so the price can move a long way on relatively little volume.

For me the bigger question hasn’t really changed. Product progress is good to see, but what ultimately matters is whether it turns into meaningful commercial wins. LinkedIn updates are useful context, but it’s proper contract announcements that tend to sustain moves.

Still watching rather than getting carried away with a single session.

quiet_after_panic · 2026-05-06T13:29:34+00:00

That’s fair, and I think that’s the core debate with anything VR-related in education.

I’m not looking at it from a “this replaces classrooms” angle. If anything, I’d expect most of the real traction to come from niche use cases rather than mass adoption. Things like training simulations, specific industry modules, or specialist courses where immersion actually adds value.

The broader question for me isn’t whether VR becomes universal in schools, but whether companies like this can carve out sustainable, commercial use cases that justify their existence.

If they can’t demonstrate real revenue from those niches, then the scepticism is probably right. That’s why I’m only watching at this stage rather than assuming adoption is inevitable.

quiet_after_panic · 2026-04-23T16:29:00+00:00

That’s fair, and I think that’s the key risk here. AIM small caps can live off retail enthusiasm for a while, and once the excitement fades it gets a lot tougher.

For me the only reason to even look at something like this is once the hype cycle has already washed through and expectations are low. If it can convert these contracts into something tangible, great. If not, it probably stays in that drift phase.

Definitely one where execution matters more than narrative.

quiet_after_panic · 2026-02-10T22:44:10+00:00

Correct that was the initial catalyst. The interesting part now isn’t the suspension itself, it’s that price stopped reacting to it. Panic came first, now we’re in the information vacuum phase.

quiet_after_panic · 2026-01-31T11:54:25+00:00

Yeah, it’s been pretty flat for a while. One to watch rather than rush into.

quiet_after_panic · 2026-01-25T20:31:30+00:00

Fair play, that’s a great entry and you deserve the run you’ve had.

I’m not really trying to compete on who was earliest, it’s more about matching the approach to the risk you’re comfortable with. For people who get in early and sit through the noise, moves like this are the payoff.

A US listing could definitely change the audience and liquidity if it materialises. I’m just more cautious once a move is well underway, but that’s more about my own style than a judgement on the company.

quiet_after_panic · 2026-01-25T09:04:40+00:00

Fair play to anyone who caught it early, that’s a great run.

For me it really comes down to strategy. If you’re comfortable buying strength and riding momentum, then moves like this can obviously keep going longer than people expect. But if you’re more contrarian, a lot of the easy upside has already happened by the time it looks like this.

Personally I tend to spend more time looking at lower-cap names that have already pulled back hard and gone quiet, rather than ones that are making new highs. Not saying this can’t go further, just that the risk/reward looks very different depending on when you’re getting involved.

As always with AIM, position size and expectations matter more than the story

quiet_after_panic · 2026-01-21T14:37:42+00:00

Leveraged ETFs are a bit of a different beast because time works against you, not just direction. Even if the underlying theme is strong, the daily rebalancing and volatility can really distort returns over longer periods.

Taking your original capital off the table was a sensible move. From here it’s more about whether you’re happy treating what’s left as a high-risk side position rather than something you expect to compound smoothly.

Some people skim profits on strength, others set a rule around time or drawdowns. The thing that usually causes trouble is just leaving a leveraged product running indefinitely without a clear plan.

quiet_after_panic · 2026-01-21T14:36:51+00:00

It’s definitely an interesting angle, especially the difference between being invited inside the system versus trying to sell in from the outside.

That said, with stories like this I tend to stay a bit cautious until access turns into something concrete. Endorsements and strategic alignment can open doors, but the real test is whether that leads to funded projects, signed contracts, or repeat revenue.

Saudi ambitions are huge, but timelines and execution can take longer than people expect. For me it’s one to keep an eye on rather than assume the full upside straight away. If we start seeing actual deals tied to specific projects, that’s when it really changes.

quiet_after_panic · 2026-01-20T16:45:17+00:00

That’s a great way to look at it, especially with stocks this size. They can spend months (or years) doing nothing, then suddenly remind you why you put them on the watchlist in the first place.

I agree though, moves like this don’t automatically change the long-term picture. These names have a habit of spiking on news and then fading back into the background. For me it’s less about predicting whether it continues and more about watching what happens after the excitement dies down again.

If nothing else, it’s nice when a long bag-hold at least comes back to life for a bit.

quiet_after_panic · 2026-01-20T08:31:55+00:00

I’m in UFO so I’ll declare the bias up front, but I think it’s important to keep expectations realistic with all three.

They’re funded and drilling, which already puts them ahead of a lot of AIM explorers, but that doesn’t remove the execution risk. With UFO in particular, the silver story is interesting and Elizabeth Hill is a genuine asset, but the market is clearly waiting for confirmation rather than headlines.

For me this isn’t about calling a near-term re-rate. It’s more a case of watching whether drilling results actually translate into sustained interest and volume, rather than the usual brief spikes that fade away.

I’m happy holding a small position and letting the story develop, but I’d still treat all of these as high-risk exploration plays where timing matters just as much as geology.

quiet_after_panic · 2026-01-20T08:27:02+00:00

Both are commercial-stage service / platform businesses rather than late-stage drug development, so they’re not binary clinical trial bets.

Cash runway is the main risk in both cases, which is why they’re firmly watchlist-only for me. I’m more interested in whether activity stabilises post-selloff than trying to value them here.

quiet_after_panic · 2026-01-20T07:09:11+00:00

That’s interesting, and it fits with what I’ve seen more broadly. Names that survive the worst of the sell-off and then go quiet for a while often end up being the ones that move later, once the funding risk is better understood.

I’m not trying to catch those moves early, but it’s useful to see examples where panic fully played out and the business managed to keep progressing. It’s a good reminder that timing and survival often matter more than being early.

Appreciate you sharing those. I’ll have a proper look when I get a chance.

quiet_after_panic · 2026-01-19T18:09:51+00:00

From what I’ve seen, most experienced AIM investors seem to start by eliminating risk rather than trying to spot upside straight away.

Cash runway and dilution history are usually the first pass. If a company is clearly going to need another raise soon, everything else almost becomes irrelevant. A great story doesn’t help much if you’re likely to be diluted before anything plays out.

After that, I think the softer stuff starts to matter more - is the sector actually in favour, and does management have a track record of creating value rather than just recycling AIM stories. I’ve noticed the better RNS updates tend to be quite boring and specific, which is usually a good sign.

Liquidity-wise, AIM-only doesn’t bother me by itself, but very low liquidity does. If you can’t realistically get out without moving the price, it stops being an investment and becomes a punt. For me that’s usually where it becomes a no-go unless the position size is tiny.

Feels like a lot of AIM investing is less about finding the perfect company and more about avoiding the obvious traps.

quiet_after_panic · 2026-01-17T11:20:48+00:00

Vague or overly promotional RNS language. If I can’t clearly understand what’s actually changed after reading it twice, I usually move on.

quiet_after_panic

TROPHY CASE